Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 30285560

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Oct 4
First author
Lockmer S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Mar 20;37(9):758. doi: 10.1200/JCO.18.01761.
    note
    Source null
    related pmid
    30735429
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Mar 20;37(9):759-760. doi: 10.1200/JCO.18.02362.
    note
    Source null
    related pmid
    30735430
    relationship
    Comment in

Authors and identifiers

  1. name
    Lockmer S
    type
    Author
  2. name
    Østenstad B
    type
    Author
  3. name
    Hagberg H
    type
    Author
  4. name
    Holte H
    type
    Author
  5. name
    Johansson AS
    type
    Author
  6. name
    Wahlin BE
    type
    Author
  7. name
    Wader KF
    type
    Author
  8. name
    Steen CB
    type
    Author
  9. name
    Meyer P
    type
    Author
  10. name
    Maisenhølder M
    type
    Author
  11. name
    Smedby KE
    type
    Author
  12. name
    Brown P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lockmer S
    type
    Author
  2. name
    Østenstad B
    type
    Author
  3. name
    Hagberg H
    type
    Author
  4. name
    Holte H
    type
    Author
  5. name
    Johansson AS
    type
    Author
  6. name
    Wahlin BE
    type
    Author
  7. name
    Wader KF
    type
    Author
  8. name
    Steen CB
    type
    Author
  9. name
    Meyer P
    type
    Author
  10. name
    Maisenhølder M
    type
    Author
  11. name
    Smedby KE
    type
    Author
  12. name
    Brown P
    type
    Author
bibliography ids
  1. nci-bib-dcdd901d2bbb755dfca9018e
book metadata
content sha256
21aaf2511632c823690aa8e23aa097c4872f716a1b5810a417a2611409852d7e
document type
citation
dois
  1. 10.1200/JCO.18.00262
electronic publication date
display
2018 Oct 4
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30285560
immutable id
pubmed:30285560@21aaf2511632c823690aa8e23aa097c4872f716a1b5810a417a2611409852d7e
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
Source null
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
JCO1800262
volume
Source null
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Mar 20;37(9):758. doi: 10.1200/JCO.18.01761.
    note
    Source null
    related pmid
    30735429
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Mar 20;37(9):759-760. doi: 10.1200/JCO.18.02362.
    note
    Source null
    related pmid
    30735430
    relationship
    Comment in
outcomes validated
false
pmid
30285560
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
1b6d1be8ec22f6892ab3eb162716013301c2f4ff0e4f752bc84fe5726a415374
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Oct 4
precision
day
year
2018
publication types
  1. Journal Article
record status
PubMed - as supplied by publisher
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30285560/
title
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.

Preserved source evidence · Independent clinical review pending · Not medical advice